Skip to content
healthcare.dev
Get a free key

ELAHERE

NDC 72903-853, MIRVETUXIMAB SORAVTANSINE, injection, solution, from ImmunoGen, Inc..

Product NDC
72903-853
Status
Listed
Labeler
ImmunoGen, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761310
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72903-853 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MIRVETUXIMAB SORAVTANSINE5 mg/mL
Package NDCNDC-11Package
72903-853-01729030853011 VIAL, SINGLE-USE in 1 CARTON (72903-853-01) / 20 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/00c424b5-6ccd-48ab-9e88-1986451120e2

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=72903-853

Use it

Look up 72903-853 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72903-853 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72903-853. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.